{"title":"The Phosphoproteomic Landscape of CD2AP: A Comprehensive Review of Kinase Networks and Disease Implications.","authors":"Akhila Sheela, Suhail Subair, Athira Perunelly Gopalakrishnan, Akhina Palollathil, Rajesh Raju","doi":"10.1177/15578100261451308","DOIUrl":null,"url":null,"abstract":"<p><p>CD2-associated protein (CD2AP) is a multifunctional adaptor linking membrane receptors to the actin cytoskeleton, ensuring slit diaphragm integrity, regulating synaptic proteostasis, and facilitating cytoskeletal remodeling. Dysregulation of CD2AP contributes to proteinuric kidney disease, Alzheimer's disease, and tumor progression. This review provides a comprehensive overview of the structural and functional characteristics of CD2AP, its phosphorylation landscape, and potential regulatory roles. By integrating 3,825 publicly available phosphoproteomic research articles with data obtained from kinase prediction tools, the study offers information on predominant phosphosites, upstream kinases, binary interactors, and disease associations of CD2AP. We identified 45 class I phosphosites with S224, S233, S256, S458, S510, and S514 being frequently regulated across biological contexts. Predictive kinase-substrate mapping and co-regulation analysis highlighted several upstream kinases whose phosphorylation patterns positively co-regulate with CD2AP modification. Co-regulated proteins associated with Alzheimer's and kidney disease, and several phosphoproteins were associated with cell movement and cancer progression. Overall, these findings position CD2AP as a dynamic signaling hub coordinating disease-related pathways.</p>","PeriodicalId":19530,"journal":{"name":"Omics A Journal of Integrative Biology","volume":" ","pages":"295-307"},"PeriodicalIF":2.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Omics A Journal of Integrative Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1177/15578100261451308","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
CD2-associated protein (CD2AP) is a multifunctional adaptor linking membrane receptors to the actin cytoskeleton, ensuring slit diaphragm integrity, regulating synaptic proteostasis, and facilitating cytoskeletal remodeling. Dysregulation of CD2AP contributes to proteinuric kidney disease, Alzheimer's disease, and tumor progression. This review provides a comprehensive overview of the structural and functional characteristics of CD2AP, its phosphorylation landscape, and potential regulatory roles. By integrating 3,825 publicly available phosphoproteomic research articles with data obtained from kinase prediction tools, the study offers information on predominant phosphosites, upstream kinases, binary interactors, and disease associations of CD2AP. We identified 45 class I phosphosites with S224, S233, S256, S458, S510, and S514 being frequently regulated across biological contexts. Predictive kinase-substrate mapping and co-regulation analysis highlighted several upstream kinases whose phosphorylation patterns positively co-regulate with CD2AP modification. Co-regulated proteins associated with Alzheimer's and kidney disease, and several phosphoproteins were associated with cell movement and cancer progression. Overall, these findings position CD2AP as a dynamic signaling hub coordinating disease-related pathways.
期刊介绍:
OMICS: A Journal of Integrative Biology is the only peer-reviewed journal covering all trans-disciplinary OMICs-related areas, including data standards and sharing; applications for personalized medicine and public health practice; and social, legal, and ethics analysis. The Journal integrates global high-throughput and systems approaches to 21st century science from “cell to society” – seen from a post-genomics perspective.